AR021808A1 - NEW COMPOSITION - Google Patents
NEW COMPOSITIONInfo
- Publication number
- AR021808A1 AR021808A1 ARP990104626A ARP990104626A AR021808A1 AR 021808 A1 AR021808 A1 AR 021808A1 AR P990104626 A ARP990104626 A AR P990104626A AR P990104626 A ARP990104626 A AR P990104626A AR 021808 A1 AR021808 A1 AR 021808A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- component
- disorders
- new composition
- diclobutylamino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invencion se refiere a una composicion que comprende un primer componente (a) que es (R)-3-N,N-diclobutilamino-8-fluor-3,4-dihidro-2H-1-benzopiran-5-carboxamida hidrogeno (2R, 3R)-tartrato monohidrato y a un segundo componente (b) que es paroxetina en forma de base libre, o una sal farmacéuticamenteaceptable y/o solvato de la misma, la preparacion del mismo, formulaciones farmacéuticas que contienen dicha composicion, uso de y un método de tratamiento detrastornos afectivos, tales como trastornos del estado de ánimo y trastornos de la ansiedad con dicha composicion, así como también un kit que contiene dichacomposicion.The invention relates to a composition comprising a first component (a) which is (R) -3-N, N-diclobutylamino-8-fluor-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen ( 2R, 3R) -tartrate monohydrate and a second component (b) which is paroxetine in the form of free base, or a pharmaceutically acceptable salt and / or solvate thereof, the preparation thereof, pharmaceutical formulations containing said composition, use of and a method of treating affective disorders, such as mood disorders and anxiety disorders with said composition, as well as a kit containing said composition.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803156A SE9803156D0 (en) | 1998-09-16 | 1998-09-16 | A new composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR021808A1 true AR021808A1 (en) | 2002-08-07 |
Family
ID=20412627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990104626A AR021808A1 (en) | 1998-09-16 | 1999-09-15 | NEW COMPOSITION |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1128825A1 (en) |
| JP (1) | JP2002524508A (en) |
| KR (1) | KR20010099647A (en) |
| CN (1) | CN1317964A (en) |
| AR (1) | AR021808A1 (en) |
| AU (1) | AU6378099A (en) |
| BR (1) | BR9913748A (en) |
| CA (1) | CA2342341A1 (en) |
| CZ (1) | CZ2001961A3 (en) |
| EE (1) | EE200100157A (en) |
| HU (1) | HUP0103544A3 (en) |
| ID (1) | ID28785A (en) |
| IL (1) | IL141519A0 (en) |
| IS (1) | IS5879A (en) |
| NO (1) | NO20011312L (en) |
| PL (1) | PL346763A1 (en) |
| SE (1) | SE9803156D0 (en) |
| SK (1) | SK3262001A3 (en) |
| TR (1) | TR200100779T2 (en) |
| WO (1) | WO2000015218A1 (en) |
| ZA (1) | ZA200101946B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE334979T1 (en) * | 2000-10-13 | 2006-08-15 | Neurosearch As | TREATMENT OF AFFECTIVE DISORDERS BY THE COMBINED ACTION OF A NICOTINIC RECEPTOR AGONIST AND A MONOAMINERGIC SUBSTANCE |
| JPWO2006093192A1 (en) * | 2005-03-04 | 2008-08-07 | 国立大学法人 東京医科歯科大学 | Stimulant psychosis and schizophrenia relapse prevention drug |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9501567D0 (en) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
-
1998
- 1998-09-16 SE SE9803156A patent/SE9803156D0/en unknown
-
1999
- 1999-09-13 CA CA002342341A patent/CA2342341A1/en not_active Abandoned
- 1999-09-13 TR TR2001/00779T patent/TR200100779T2/en unknown
- 1999-09-13 BR BR9913748-8A patent/BR9913748A/en not_active Application Discontinuation
- 1999-09-13 PL PL99346763A patent/PL346763A1/en unknown
- 1999-09-13 EP EP99951319A patent/EP1128825A1/en not_active Withdrawn
- 1999-09-13 IL IL14151999A patent/IL141519A0/en unknown
- 1999-09-13 KR KR1020017003337A patent/KR20010099647A/en not_active Application Discontinuation
- 1999-09-13 CN CN99811010A patent/CN1317964A/en active Pending
- 1999-09-13 JP JP2000569802A patent/JP2002524508A/en active Pending
- 1999-09-13 ID IDW20010581A patent/ID28785A/en unknown
- 1999-09-13 EE EEP200100157A patent/EE200100157A/en unknown
- 1999-09-13 SK SK326-2001A patent/SK3262001A3/en unknown
- 1999-09-13 HU HU0103544A patent/HUP0103544A3/en unknown
- 1999-09-13 AU AU63780/99A patent/AU6378099A/en not_active Abandoned
- 1999-09-13 WO PCT/SE1999/001597 patent/WO2000015218A1/en not_active Application Discontinuation
- 1999-09-13 CZ CZ2001961A patent/CZ2001961A3/en unknown
- 1999-09-15 AR ARP990104626A patent/AR021808A1/en not_active Application Discontinuation
-
2001
- 2001-03-07 IS IS5879A patent/IS5879A/en unknown
- 2001-03-08 ZA ZA200101946A patent/ZA200101946B/en unknown
- 2001-03-15 NO NO20011312A patent/NO20011312L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ID28785A (en) | 2001-07-05 |
| CN1317964A (en) | 2001-10-17 |
| JP2002524508A (en) | 2002-08-06 |
| HUP0103544A2 (en) | 2002-05-29 |
| NO20011312D0 (en) | 2001-03-15 |
| SK3262001A3 (en) | 2001-08-06 |
| AU6378099A (en) | 2000-04-03 |
| CZ2001961A3 (en) | 2001-08-15 |
| BR9913748A (en) | 2001-07-10 |
| EP1128825A1 (en) | 2001-09-05 |
| KR20010099647A (en) | 2001-11-09 |
| ZA200101946B (en) | 2002-06-10 |
| CA2342341A1 (en) | 2000-03-23 |
| IL141519A0 (en) | 2002-03-10 |
| HUP0103544A3 (en) | 2003-12-29 |
| NO20011312L (en) | 2001-05-16 |
| PL346763A1 (en) | 2002-02-25 |
| SE9803156D0 (en) | 1998-09-16 |
| EE200100157A (en) | 2002-08-15 |
| TR200100779T2 (en) | 2001-10-22 |
| IS5879A (en) | 2001-03-07 |
| WO2000015218A1 (en) | 2000-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9501567D0 (en) | A new combination | |
| AR015448A1 (en) | COMBINATION OF A 5-HT REABSORTION INHIBITOR WITH AN H5-HT1B ANTIGONIST OR PARTIAL AGONIST, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATION CONTAINING IT, ITS USE TO PREPARE MEDICINES TO TREAT KITTEN | |
| MY125414A (en) | Aminopropylphosphinic acids | |
| GT200100153A (en) | 1,4-DIHYDROPIRIDINE COMPOUNDS AS BRADIQUININE ANTAGONISTS. | |
| ECSP024364A (en) | ADENOSINE A2A RECEIVING ANTAGONISTS | |
| KR980000447A (en) | Pharmaceutical composition consisting of mirtazapine and one or more selective serotonin reuse inhibitors | |
| AR048336A1 (en) | HYDROCLORIDE OF (4- (5-AMINOMETIL-2-FLUORO-PHENYL) -PIPERIDIN-1-IL) - (4-BROMO-3-METHYL-5-PROPOXI-TIOFEN-2-IL) -METANONE AS AN INHIBITOR OF THE MASTOCYT TRIPTASE | |
| CL2011000144A1 (en) | Compounds derived from benzo (1,4) dioxin-2-ylmethyl-sulfamide; pharmaceutical compositions containing them; process to prepare them and use in the treatment of anxiety, epilepsy, pain, substance abuse, related disorders, among others. | |
| BRPI0414428A (en) | pharmaceutical compositions | |
| PT1238676E (en) | Combination of a serotonin reuptake inhibitor with an antipsychotic for use in depression in compulsive obsessive pathology and in PSYCHOSIS | |
| BR0109672A (en) | Use of zd6126 or a pharmaceutically acceptable salt thereof and one of: a plantin antitumor agent and a taxane, pharmaceutical composition, combination product, kit, and method for producing a vascularly damaging effect on a warm-blooded animal | |
| SE0102055D0 (en) | New Compounds | |
| AR013503A1 (en) | A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A SELECTIVE H5-HT (1B) ANTAGONIST OR PARTIAL AGONIST, PHARMACEUTICAL FORMULATION, USES AND PREPARATION METHOD | |
| EP1254668A3 (en) | Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression | |
| BR9810773A (en) | Use of a long-acting local anesthetic ingredient, pharmaceutical composition, use of a local anesthetic, and, kit | |
| UA87980C2 (en) | Composition for improving cognition and memory | |
| CL2002001701A1 (en) | Use of at least one compound selected from melatonin, melatoninergic agents, melatonin agonists and antagonists, in an amount of 0.0025-50 mg, to prepare a useful medicine for the treatment and improvement of the restorative quality of sleep. | |
| AR021808A1 (en) | NEW COMPOSITION | |
| SE9804126D0 (en) | New pharmaceutical composition | |
| AR045423A1 (en) | COMBINATIONS OF ANALYTICS AND ANTIDEPRESSANTS | |
| AR023657A1 (en) | COMPOSITION, USES OF THE SAME, PHARMACEUTICAL FORMULATION, PROCESS FOR THE PREPARATION OF COMPOSITION AND KIT | |
| AR033779A1 (en) | USEFUL COMPOUNDS IN REFLUX DISEASE | |
| BR0009194A (en) | Composition of resorcinol | |
| BR0210063A (en) | Stable composition and use | |
| BR9812234A (en) | Combination of components, use of this, processes for its preparation, for the treatment of affective disorders, for the treatment of depression, and to improve the beginning of therapeutic action, pharmaceutical formulation, and, kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |